tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
US Market
STOK
Stoke Therapeutics
RESEARCH TOOLSreports
Want to see STOK full AI Analyst Report?

Stoke Therapeutics (STOK) Income Statement

469 Followers

Stoke Therapeutics Income Statement

Last quarter (Q4 2025), Stoke Therapeutics's total revenue was $1.40M, a decrease of -93.80% from the same quarter last year. In Q4, Stoke Therapeutics's net income was $-57.93M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Gross Profit
$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Operating Expenses
$ 205.01M$ 137.93M$ 123.55M$ 116.76M$ 86.06M
Depreciation and Amortization
$ 1.77M$ 2.18M$ 2.47M$ 1.55M$ 974.00K
EBITDA
$ -18.82M$ -99.19M$ -112.30M$ -102.81M$ -85.09M
Operating Income
$ -20.59M$ -101.37M$ -114.77M$ -104.36M$ -86.06M
Other Income/Expenses
$ 13.71M$ 12.39M$ 10.07M$ 3.29M$ 260.00K
Pretax Income
$ -6.88M$ -88.98M$ -104.70M$ -101.07M$ -85.81M
Net Income
$ -6.88M$ -88.98M$ -104.70M$ -101.07M$ -85.81M
Per Share Metrics
Basic EPS
$ -0.12$ -1.65$ -2.38$ -2.60$ -2.34
Diluted EPS
$ -0.12$ -1.65$ -2.38$ -2.60$ -2.34
Weighted Average Shares Outstanding
 59.22M 54.01M 43.99M 38.90M 36.74M
Weighted Average Shares Outstanding (Diluted)
 59.22M 54.01M 43.99M 38.90M 36.74M
Currency in USD

Stoke Therapeutics Earnings and Revenue History